Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Cash from Financing Activities (2016 - 2025)

Myriad Genetics (MYGN) has disclosed Cash from Financing Activities for 17 consecutive years, with -$8.2 million as the latest value for Q4 2025.

  • Quarterly Cash from Financing Activities fell 490.48% to -$8.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $64.2 million through Dec 2025, up 967.57% year-over-year, with the annual reading at $64.2 million for FY2025, 967.57% up from the prior year.
  • Cash from Financing Activities for Q4 2025 was -$8.2 million at Myriad Genetics, down from $56.2 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $121.9 million in Q4 2023, with the low at -$74.5 million in Q3 2021.
  • Average Cash from Financing Activities over 5 years is $2.6 million, with a median of -$2.3 million recorded in 2022.
  • The sharpest move saw Cash from Financing Activities plummeted 24350.0% in 2021, then soared 5904.76% in 2023.
  • Over 5 years, Cash from Financing Activities stood at -$1.1 million in 2021, then plummeted by 90.91% to -$2.1 million in 2022, then skyrocketed by 5904.76% to $121.9 million in 2023, then plummeted by 98.28% to $2.1 million in 2024, then tumbled by 490.48% to -$8.2 million in 2025.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at -$8.2 million, $56.2 million, and $2.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.